Can Destroying Senescent Cells Treat Age-Related Disease?

A handful of clinical trials are underway to find out whether drugs that target senescent cells can slow the ravages of old age.

katya katarina zimmer
| 33 min read

Register for free to listen to this article
Listen with Speechify
0:00
33:00
Share

ABOVE: © BIRGIT RITSCHKA

The little black mouse’s feet dangled above the table as the animal clutched a horizontal wire with its two front paws. After just a few seconds, it lost its grip and fell onto a pile of bedding below. For a mouse its age—just six months old, typically its physical prime—that was quite unusual. As Mayo Clinic veterinary technicians Christina Inman and Kurt Johnson knew, young mice would usually manage to hoist their hind legs up to the wire so that they’re hanging from all four limbs, allowing them to last minutes, sometimes even hours, on the endurance test.

It was late 2016, and the two vet techs were in charge of testing the physical performance of dozens of young mice as part of a study led by Mayo geriatrician and aging researcher James Kirkland. The experiment was blinded, so Inman and Johnson knew nothing of the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • katya katarina zimmer

    Katarina Zimmer

    After a year teaching an algorithm to differentiate between the echolocation calls of different bat species, Katarina decided she was simply too greedy to focus on one field. Following an internship with The Scientist in 2017, she has been happily freelancing for a number of publications, covering everything from climate change to oncology.

Published In

March 2020

Rising Seas, Dead Trees

Ghost forests are a warning about climate change

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours